Abstract
The effect of Wobenzym on hemostasis, rheological properties of blood, and the clinical course of the disease when included in the complex therapy of angina pectoris was studied. It has been established that Wobenzym improves the rheologicalproperties of blood by reducing the aggregation ability of erythrocytes and platelets andincreasing the deform- ability of erythrocyte membranes. Wobenzym helps optimize the activity of the fibrinolytic and coagulation systems of the blood, improves the clinical course of angina pectoris and the quality of life of patients. The use of Wobenzym as part of complex therapy for patients with angina pectoris of functional class II is clinically justified, effective and safe.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.